| 0.62 Data as of May 14 | 0.00 / 0.00%Today’s Change | 0.57 Today|||52-Week Range 1.65 | -41.51% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Other | MARKET CAP $28.6M |
Company Description
SkyePharma Plc is a UK based pharmaceutical company. It engages in the research and development, licensing, manufacturing, marketing and distribution of prescription pharmaceutical products. The company develops new formulations of known molecules to provide a clinical advantage and life-cycle extension. The firm approves products in the areas of oral, inhalation and topical delivery. The company's products are marketed throughout the world by leading pharmaceutical companies. It has operations in France, Jersey, Switzerland, United Kingdom and the United States of America. The company was founded by Ian Roderick Gowrie-Smith in 1996 and is headquartered in London, the United Kingdom.
Employees

Shareholders
| Mutual fund holders | 0.00% |
| Other institutional | 0.00% |
| Individual stakeholders | -- |
Top Executives
| Peter L. Grant, PhD | Chief Executive Officer & Executive Director |
| Kirsten Kaiser, PhD | Executive VP-Medical & Regulatory Development |
| Geraldine Venthoye, PhD | Vice President-Pharmaceutical Development |
| Guy Vergnault, PhD | Vice President-Oral Drug Delivery Solutions |
| Pierre Delavaud, PhD | Executive VP-Sales & Business Development |